Molecular genetics of maturity-onset diabetes of the young

Trends in Endocrinology and Metabolism

Volumn 10, Issue 4, 1999, Pages 142-146

  Froguel, Philippe ^a   Velho, Gilberto ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 4; INSULIN; INSULIN PROMOTER FACTOR 1; NUCLEAR FACTOR I; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0033058487     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00134-9     Document Type: Review

References (48)

1. Velho G., Froguel P. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur. J. Endocrinol. 138:1998;233-239.
2. Bell G.I.et al. Gene for non insulin dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to DNA polymorphism on chromosome 20q. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1484-1488.
3. Yamagata K.et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 384:1996;458-460.
4. Froguel P.et al. The glucokinase locus on chromosome 7p is closely linked to early onset non insulin dependent diabetes mellitus. Nature. 356:1992;162-164.
5. Froguel P.et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. New Engl. J. Med. 328:1993;697-702.
6. Velho G.et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia. 40:1997;217-224.
7. Vaxillaire M.et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat. Genet. 9:1995;418-423.
8. Yamagata K.et al. Mutations in the hepatocyte nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384:1996;455-458.
9. Vaxillaire M.et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum. Mol. Genet. 6:1997;583-586.
10. Stoffers D.A., Zinkin N.T., Stanojevic V., Clarke W.L., Habener J.F. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15:1997;106-110.
11. Stoffers D.A., Ferrer J., Clarke W.L., Habener J.F. Early-onset type 2 diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17:1997;138-139.
12. Horikawa Y.et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet. 17:1997;384-385.
13. Chèvre J.C.et al. Mutation screening in 18 Caucasian families suggests the existence of other MODY genes. Diabetologia. 41:1998;1017-1023.
14. Ledermann H.M. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet. 345:1995;648.
15. Frayling T.M.et al. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes. 46:1997;720-725.
16. Matschinsky F.M. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 45:1996;223-241.
17. Blanché H.et al. Criblage moléculaire de la glucokinase: 37 nouvelles mutations. Diabetes Metabol. 23(Suppl. 1):1997;29. (abstr.).
18. Gidh-Jain M.et al. Glucokinase mutations associated with non insulin dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1932-1936.
19. Sturis J.et al. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations. Diabetes. 43:1994;718-723.
20. Velho G.et al. Primary pancreatic beta-cell secretory defect caused by mutations in the glucokinase in kindreds of maturity onset diabetes of the young. Lancet. 340:1992;444-448.
21. Byrne M.M.et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J. Clin. Invest. 93:1994;1120-1130.
22. Velho G.et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J. Clin. Invest. 98:1996;1755-1761.
23. Velho G., Vaxillaire M., Boccio V., Charpentier G., Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY-3 locus on chromosome 12q. Diabetes Care. 19:1996;915-919.
24. Tronche F., Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. BioEssays. 14:1992;579-587.
25. Chévre J.C.et al. Mutation screening of the hepatocyte nuclear factor-1α and 4α genes in MODY families: suggestion of the existence of at least a fourth MODY gene. Diabetologia. 40(Suppl. 1):1997;A157. (abstr.).
26. Boutin P.et al. An automated fluorescent SSCP technique for screening for mutations of the hepatocyte nuclear factor 1 alpha gene (MODY3). Diabetes. 46:1997;2108-2109.
27. Glucksmann M.A.et al. Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes. 46:1997;1081-1086.
28. Hansen T.et al. Novel MODY3 mutations in the hepatocyte nuclear factor-1 alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes. 46:1997;726-730.
29. Kaisaki P.J.et al. Mutations in the hepatocyte nuclear factor-1 alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes. 46:1997;528-535.
30. Boutin P.et al. GGC→AGC variation (Gly574Ser) in the gene MODY3/HNF-1α and recent onset diabetes in African- Americans. Diabetologia. 42:1999;380-385.
31. Byrne M.M.et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY on chromosome 12. Diabetes. 45:1996;1503-1510.
32. Isomaa B.et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia. 41:1998;467-473.
33. Velho G.et al. Renal proximal tubular defects associated to the MODY3 phenotype. Diabetologia. 41(Suppl. 1):1998;A108. (abstr.).
34. Pontoglio M.et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 84:1996;572-585.
35. Pontoglio M.et al. Defective insulin secretion in hepatocyte nuclear factor 1 alpha-deficient mice. J. Clin. Invest. 101:1998;2215-2222.
36. Vaxillaire M.et al. MODY3 mutations affect transcriptional activity of hepatocyte nuclear factor 1 alpha. Diabetologia. 41(Suppl. 1):1998;A185.
37. Lindner T.et al. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4 alpha 1/MODY1 gene. J. Clin. Invest. 100:1997;1400-1405.
38. Furuta H.et al. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes. 46:1997;1652-1657.
39. Bulman M.P.et al. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia. 40:1997;859-862.
40. Fajans S.S., Bell G.I., Bowden D.W., Halter J.B., Polonsky K.S. Maturity-onset diabetes of the young. Life Sci. 55:1994;413-422.
41. Herman W.H.et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes. 43:1994;40-46.
42. Byrne M.M.et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes. 44:1995;699-704.
43. Hertz R., Magenheim J., Berman I., Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor 4 alpha. Nature. 392:1998;512-516.
44. Nishigori H.et al. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1 beta gene associated with diabetes and renal dysfunction. Diabetes. 47:1998;1354-1355.
45. Jonsson J., Carisson L., Edlund T., Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 371:1994;606-609.
46. Iwasaki N.et al. Mutations in the hepatocyte nuclear factor-1 alpha/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes. 46:1997;1504-1508.
47. Urhammer S.A.et al. Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM. Diabetologia. 40:1997;473-475.
48. Hani E.H.et al. A missense mutation in the hepatocyte nuclear factor 4-alpha, resulting in a reduced transactivational activity, in human late-onset non insulin-dependent diabetes mellitus. J. Clin. Invest. 101:1998;521-526.